Top Performing Canada-Listed Cannabis Stocks

The Canada-listed cannabis stocks we’ve dug up have delivered strong price appreciation of over 100% YTD in 2019

SmallCapPower | April 25, 2019: Today we have discovered five Canada-listed cannabis stocks that have delivered strong price appreciation of over 100% YTD in 2019. Continued favourable market outlook for cannabis and strong growth in revenue in the first quarter post legalization are the primary reasons driving stocks in this space.

*Market caps are based on the closing price on April 23, 2019

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here      

MediPharm Labs Corp. (TSXV: LABS)

MediPharm Labs is exclusively focused on cannabis oil extraction. The Company operates a cGMP facility and ISO-rated laboratory clean rooms in Barrie, Ontario to produce purified, pharma-grade cannabis oil. Due to its differentiated extracts-only business model, MediPharm acts as an agnostic partner to any licensed producer, providing both White Label Production and Contract Processing. As part of its international strategy, MediPharm is currently developing an extraction facility in Australia, expected to be completed in H2 2019. On April 3, 2019, MediPharm reported fourth-quarter revenue of $10.2 million and adjusted EBITDA of $2.1 million.

  • Market Cap: $658.5 Million
  • YTD price change: 247.7%

Did you know that Ubika Alpha initiated coverage of MediPharm Labs shares on January 18, 2019 at a price of $1.96? Read the original report here

Pharmacielo Ltd. (TSXV:PCLO)

Pharmacielo cultivates and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. The Company believes it is the world’s largest licensed producer of cannabis, with annual flowering capacity of 5.5 million kgs. On February 11, 2019, PharmaCielo received a proprietary license for 10 unique CBD and THC strains under Colombia’s national cultivar registry.

  • Market Cap: $793.0 Million
  • YTD price change: 229.1%

Valens GroWorks Corp. (CSE:VGW)

Valens GroWorks is a research-driven company focused primarily on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification, as well as associated quality  testing. On April 9, 2019, the Company announced the closing of a $43.1 million bought-deal financing that will be used for increasing extraction capacity at its Kelowna facility, build out the recently-acquired adjacent property to add additional post processing, product development and white label capacity.

  • Market Cap: $382.2 Million
  • YTD price change: 171.5%

Flower One Holdings Inc. (CSE:FONE)

Flower One Holdings is currently focused on developing and advancing its 455,000 sq.ft greenhouse and production facility, the largest in Nevada, to production.  The Company also owns and operates a 25,000 sq.ft. indoor cultivation and production facility in North Las Vegas and owns the NLV Organics consumer brand of cannabis products.

  • Market Cap: $597.3 Million
  • YTD price change: 138.6%

Curaleaf Holdings Inc. (CSE:CURA)

Curaleaf Holdings is a vertically-integrated multi-state cannabis operator in the U.S., present in 12 states with 43 dispensaries, 13 cultivation sites and 11 processing sites. On April 1, 2019, Curaleaf acquired EC Investment Partners, LLC, strengthening its position in California, the largest cannabis market in the U.S.

  • Market Cap: $4,831 Million
  • YTD price change: 122.9%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: